Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a medical gas mixture composed of carbon dioxide, oxygen, and nitrogen in varying proportions. It is supplied as a compressed gas for respiratory administration by inhalation. The specific formulation may vary but typically contains approximately 5% carbon dioxide, 20% oxygen, and 75% nitrogen per liter. This combination is used under the supervision of healthcare professionals for specialized clinical applications such as respiratory stimulation testing or calibration of medical devices[6][8]. The mechanism involves providing controlled concentrations of these gases to influence respiration and other physiological parameters.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carbon dioxide + oxygen + nitrogen.